On 16 April 2026 the FDA removed BPC-157 and 11 other peptides from Category 2, and a Pharmacy Compounding Advisory Committee (PCAC) hearing on 23 and 24 July 2026 is now reviewing whether to add BPC-157, alongside TB-500, KPV, MOTS-C, DSIP, Semax and Epitalon, to the 503A "positive bulks list" (see our FDA PCAC July 2026 explainer)
Investigation of MTHFR in psychiatric diseases has important clinical implications, such as identification role of MTHFR and its genotypes in the psychiatric patients who respond or not respond to traditional pharmacological treatment for personalized treatment management of psychiatric diseases
Consult with your physician to identify the best treatment for your condition
Yamamoto Nutrition Carnitine 1000 un integratore alimentare di Carnitina in compresse da 1000 mg, (Carnitina tartrato), utile in caso di ridotto apporto con la dieta di questo nutriente
- - (L-Carnitine Plus)
(October 18, 2025) Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study